Lilly reports Q3 2024 financial results highlighted by strong …
INDIANAPOLIS, Oct. 30, 2024 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today announced its financial results for the third quarter of 2024. "Lilly had another strong growth quarter in Q3, with total revenue increasing by 42% after excluding divestiture activity in the same period last year," said David A. Ricks, Lilly chair and CEO ...
All News - Eli Lilly and Company
Oct 28, 2024 · Lilly's latest press releases, stories, news resources and more.
Lilly announces new $4.5 billion site - the Lilly Medicine Foundry
INDIANAPOLIS, Oct. 2, 2024 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today announced a $4.5 billion investment to create the Lilly Medicine Foundry, a new center for advanced manufacturing and drug development.
Lilly appoints Thomas J. Fuchs as the company’s first chief AI officer
October 8, 2024. PDF Version. INDIANAPOLIS, Oct. 8, 2024— Today, Eli Lilly and Company (NYSE: LLY) announced the appointment of Thomas J. Fuchs, Dr.sc., as its first chief AI officer, effective Oct. 21, 2024. In this role, Fuchs will provide vision, strategic direction and overall leadership of AI initiatives across Lilly, including drug ...
Lilly.com | Eli Lilly and Company
INDIANAPOLIS , Oct. 16, 2024 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) will announce its third-quarter 2024 financial results on Oct. 30, 2024 . Lilly will also conduct a conference call that day with the investment community and media to further detail the company's financial performance.
Lilly hits record high after Mounjaro fuels forecast raise, rival data
Aug 8 (Reuters) - Eli Lilly (LLY.N) on Tuesday raised its annual forecasts as demand for new diabetes drug Mounjaro surges ahead of a decision on its use as a weight-loss treatment, with shares...
A Medicine Company | Eli Lilly and Company
A Medicine Company | Eli Lilly and Company. Learn the latest information on the availability of Lilly diabetes and obesity medicines. Learn how to protect yourself from counterfeit Mounjaro ® and Zepbound ® and unapproved tirzepatide products. Better Access to …
News Release - Eli Lilly and Company
INDIANAPOLIS, May 24, 2024 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) announced today that it has more than doubled its investment in its Lebanon, Indiana, manufacturing site with a new $5.3 billion commitment, increasing the company's total investment in this site from $3.7 billion to $9 billion.
Eli Lilly and Company - The New York Times
News about Eli Lilly and Company, including commentary and archival articles published in The New York Times.
Lilly drug slows Alzheimer's by 35%, bolstering treatment approach
May 3, 2023 · An experimental Alzheimer's drug developed by Eli Lilly and Co slowed cognitive decline by 35% in a late-stage trial, the company said on Wednesday, providing what experts say is the strongest...